| Methods |
Randomized, double‐blind, placebo‐controlled.
Weight loss trial. |
| Participants |
50 patients with dyslipidemia. 1 year follow‐up. Mean age 52 y. Mean BMI 31.9 kg/m2. Mean weight 95 kg. Italy. |
| Interventions |
Orlistat 120 mg tid (n=27). Attrition rate 7%.
Placebo (n=23). Attrition rate 0%. |
| Outcomes |
weight loss, waist circ, BMI, lipid profile, blood pressure |
| Notes |
Co‐interventions: 1500 kcal/d diet, exercise. Data for fluvastatin and orlistat/fluvastatin arm not presented in this review. |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Low risk |
A ‐ Adequate |
